Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic approach for long QT syndrome

Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic approach for long QT syndrome

US Patent 9434947 · Granted Sep 6, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Flexible printed circuit board and display apparatus2025
Iterative hierarchical processing and validation of hierarchical data in a tempo2025
Touch sensor and display apparatus2025
Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic appr2018
Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic appr2018
Modulation of KCNH2 isoform expression by oligonucleotides as a therapeutic appr2018